ANeuroTech publishes Phase IIIa data for ANT-01
31 Jan 2024 //
GLOBENEWSWIRE
ANeuroTech receives FDA approval for Phase IIIb MDD drug trial
06 Jun 2023 //
CLINICAL TRIALS ARENA
ANeuroTech receives IND approval from the FDA for ANT-01
05 Jun 2023 //
GLOBENEWSWIRE